Peptide Antagonists of Ethanol Inhibition of L1-Mediated Cell-Cell Adhesion

  1. Michael F. Wilkemeyer1,
  2. Carrie E. Menkari1,
  3. Catherine Y. Spong2 and
  4. Michael E. Charness1
  1. Neurology Service, Veterans Administration Boston Healthcare System, West Roxbury, Massachusetts; Department of Neurology, Harvard Medical School, Boston, Massachusetts; 1Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts (M.F.W., C.E.M., M.E.C.); and 2Section on Developmental and Molecular Pharmacology, Laboratory of Developmental Neurobiology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland (C.Y.S.)
  1. Dr. Michael E. Charness, Department of Neurology (127), Harvard Medical School, Veterans Administration Boston Healthcare System, 1400 VFW Parkway, West Roxbury, MA 02132. E-mail: mcharness{at}hms.harvard.edu

Abstract

Ethanol inhibits cell-cell adhesion mediated by the L1 cell adhesion molecule. 1-Octanol potently antagonizes this cellular action of ethanol and also prevents ethanol-induced dysmorphology and cell death in mouse whole embryo culture. NAPVSIPQ (NAP) and SALLRSIPA (SAL) are active peptide fragments of two neuroprotective proteins: activity-dependent neuroprotective protein and activity-dependent neurotrophic factor. NAP and SAL are neuroprotective at femtomolar concentrations against a variety of neurotoxins and also prevent ethanol teratogenesis in mice. To explore the cellular basis for this action, we asked whether NAP and SAL antagonize ethanol inhibition of L1 adhesion. Aggregation assays were carried out in ethanol-sensitive, human L1-transfected NIH/3T3 cells in the absence and presence of NAP and SAL. Neither NAP nor SAL altered L1 adhesion or L1 expression; however, both peptides potently and completely antagonized the inhibition of L1 adhesion by 100 mM ethanol (EC50: NAP, 6 × 10−14 M; SAL, 4 × 10−11 M). NAP also antagonized ethanol inhibition of cell-cell adhesion in bone morphogenetic protein-7-treated NG108-15 cells. In L1-expressing NIH/3T3 cells, SAL antagonism was reversible and could be overcome by increasing concentrations of ethanol. In contrast, NAP antagonism was irreversible and could not be overcome by increasing agonist concentration. Two scrambled NAP peptides (ASPNQPIV and PNIQVASP) were not antagonists at concentrations as high as 10−7 M. Thus, two structurally unrelated classes of compounds, alcohols and small polypeptides, share two common actions: antagonism of ethanol inhibition of L1-mediated cell adhesion and prevention of ethanol teratogenesis. These findings support the hypothesis that ethanol inhibition of L1 adhesion contributes to ethanol teratogenesis.

Footnotes

  • This study was supported by U.S. Public Health Service (AA12974 and AA11297), the Medical Research Service, Department of Veterans Affairs (to M.E.C. and M.F.W.), and by the Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health (to C.Y.S.).

  • DOI: 10.1124/jpet.102.036277

  • Abbreviations:
    FAS
    fetal alcohol syndrome
    SAL
    SALLRSIPA
    NAP
    NAPVSIPQ
    ADNF
    activity-dependent neurotrophic factor
    PBS
    phosphate-buffered saline
    BMP-7
    bone morphogenetic protein-7
    N-CAM
    neural cell adhesion molecule
    • Received March 15, 2002.
    • Accepted May 23, 2002.
« Previous | Next Article »Table of Contents